ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

London-based AI drug discovery firm Isomorphic Labs raised $5bn in a Series C round co-led by Greenoaks and Sequoia Capital. The funding, occurring six months after a $2.1bn Series B, includes new investors like Andreessen Horowitz and Alphabet. CEO Demis Hassabis stepped back from Google DeepMind in August.
Tap to vote and see what everyone thinks.
Summary by ByteBrief